Feature

Revolutionising the treatment of respiratory disease

Medical device developer Wideblue has worked with client TidalSense over the past 10 years, to produce the world’s first handheld capnometer targeting the management of chronic respiratory conditions.

04/12/2023 15:33:01

Traditionally, capnometers have been used in hospitals as an essential tool during anaesthesia and intensive care, to track respiratory failure. Evidence has suggested that capnometry could be used to identify airway obstruction associated with asthma and chronic obstructive pulmonary disease (COPD).

These diseases affect almost 10 percent of the world’s population, with COPD now listed as the third leading cause of death worldwide. This is predominantly driven by smoking and air pollution. Yet, advances in respiratory care management have not kept pace. Late and inaccurate diagnosis of these conditions results in billions of pounds in healthcare costs, through exacerbations leading to hospitalisations, many of which are preventable.

The challenge for Wideblue was to support TidalSense in designing an easy-to-use handheld device which could collect breath waveform data for use in a GP’s surgery or the patient’s home, and securely transmit the data to a remote server.

Read the full article in DPA's December issue

Written By Sophia Bell

Sophia Bell is the Group Editor of DPA, Connectivity, and PBSI. She joined the team in 2020 as Assistant Editor after achieving a First-Class Honours BA in English Literature and Film Studies from the University of East Anglia. In her current role, she leads the editorial strategy, driving digital growth and ensuring each title continues to deliver trusted, relevant insight for engineering and manufacturing professionals.